Randall Moorman, MD

Randall J. Moorman is a clinical cardiologist. He received his undergraduate and medical degrees from the University of Mississippi and completed his clinical training at Duke. 

Moorman has over 5 years of experience in developing bedside predictive analytic tools for clinicians based on mathematical analysis and physiological monitoring in hospital patients. 

He was the Principal Investigator of the HeRO trial of heart rate characteristics (HRC) monitoring for early detection of sepsis in premature infants. The trial showed that HeRO monitoring reduced the death rate by more than 20%, and in 2012, it was named one of the Top 12 scientific discoveries within the last 50 years at the University of Virginia. 

With JS Richman, he developed sample entropy, a popular measure of complexity in dynamical systems.  He has worked closely with DE Lake for more than 20 years in applied mathematics of clinical time series.

More recently, he co-founded and was Chief Medical Officer of Advanced Medical Predictive Devices, Diagnostics, and Displays (AMP3D), acquired in 2021 by medical electronics manufacturer Nihon Kohden, where he developed CoMET, an analytics software for early detection of imminent catastrophic illness. 

He is co-MPI in the large NIH BRIDGE2AI data generation program CHoRUS, which will provide data from more   than 100,000 ICU patients for AI development.